ArticleAmerican journal of stem cells2013
Genetic instability of modified stem cells - a first step towards malignant transformation?
Article in American journal of stem cells, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 28 citations in OpenAlex.
- Altered genome induced immune response of iPSCs.Frontiers in immunology · 2026Article
- Article
- Human ESC-derived Neuromesodermal Progenitors (NMPs) Successfully Differentiate into Mesenchymal Stem Cells (MSCs).Stem cell reviews and reports · 2022Article
- Regenerative medicine applications: An overview of clinical trials.Frontiers in bioengineering and biotechnology · 2022Review
- Review
- Acquired genetic changes in human pluripotent stem cells: origins and consequences.Nature reviews. Molecular cell biology · 2020Review
- Advances in regenerative therapy: A review of the literature and future directions.Regenerative therapy · 2020Review
- Stem cell therapy: old challenges and new solutions.Molecular biology reports · 2020Review
- 21st Century Cell Culture for 21st Century Toxicology.Chemical research in toxicology · 2017Article
- Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases.Molecular brain · 2016Article
- Nuclear reprogramming with a non-integrating human RNA virus.Stem cell research & therapy · 2015Article
- Molecular mechanism of extrinsic factors affecting anti-aging of stem cells.World journal of stem cells · 2015Review
- Mesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Ischemia and Reperfusion Injury.Journal of immunology research · 2015Article
- Ethics of iPSC-based clinical research for age-related macular degeneration: patient-centered risk-benefit analysis.Stem cell reviews and reports · 2014Article
- Interaction between nonviral reprogrammed fibroblast stem cells and trophic factors for brain repair.Molecular neurobiology · 2014Article
- Stem cells in plastic surgery: a review of current clinical and translational applications.Archives of plastic surgery · 2013Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Induced pluripotent stem cells (iPSC) are important tools in regenerative medicine. Yet, it is becoming increasingly clear that the reprogramming process, including retroviral transduction with potent oncogenes like c-Myc and long-term cultivation, may induce genetic instability. Genetically altered iPS cells can grow out and dominate the cell culture. This review intends to comprehensively summarize the current knowledge on genetic instability of embryonic and iPSCs, with an emphasis on cytogenetic alterations, and compares these data with what is known from tumorigenesis.
Indexed as
Identifiers
23671815PMC3636728W134267942What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.